Abstract
The first clinical transcatheter embolization procedure was reported in 1972, utilizing autologous clot as the embolic agent. Since then, embolization procedures have become progressively more sophisticated and the number, variety, and complexity of embolic agents has exponentially increased. Hence, one of the most difficult decisions an operator must make before any given embolization procedure is what embolic agent to use.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
